BioCryst Pharmaceuticals
The SVP, Global Quality Assurance provides enterprise leadership for BioCryst’s global Quality organization and GxP Quality strategy across development, clinical, commercial, distribution, and post-market operations. This role defines and advances a fit-for-purpose Quality vision, culture, and Quality Management System that enable compliant, scalable, and reliable execution while serving as a competitive advantage for BioCryst. Working closely with the executive leadership team and key cross-functional partners, the SVP drives inspection readiness, risk-based decision-making, continuous improvement, and digital and AI-enabled modernization of the QMS.
Headquarters
Durham, North Carolina, United States
Company Size
501-1000 employees
Founded
1986
BioCryst Pharmaceuticals is a global biotech company with over three decades of experience in drug discovery, development, and commercialization, specializing in rare disease therapeutics. Founded in 1986, the company focuses on hereditary angioedema (HAE) and other rare diseases, delivering first-in-class or best-in-class oral small-molecule and injectable protein therapeutics. BioCryst uses a novel, structure-guided approach blending traditional biology and medicinal chemistry with advanced technologies to develop medicines for underserved patient communities worldwide.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for BioCryst Pharmaceuticals.
BioCryst Pharmaceuticals didn’t post a salary, so this is our estimate from similar listings.